Literature DB >> 12534451

Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes.

K Højlund1, M Poulsen, P Staehr, K Brusgaard, H Beck-Nielsen.   

Abstract

BACKGROUND: Protein phosphatase 2A (PP2A) acts on a number of enzymes involved in the insulin regulation of glucose uptake and glycogen synthesis. This study was carried out to investigate the effect of insulin on PP2A expression in skeletal muscles of type 2 diabetic and control subjects.
MATERIAL AND METHODS: Ten type 2 diabetic and 10 matched, control subjects were studied using the euglycaemic-hyperinsulinaemic clamp technique combined with indirect calorimetry. Immunoreactive protein levels of the catalytic alpha subunit of PP2A (PP2A-C alpha) were measured in biopsies from the vastus lateralis muscle obtained in the basal and insulin-stimulated state.
RESULTS: In type 2 diabetic subjects insulin-mediated glucose disposal, glucose oxidation and nonoxidative glucose metabolism were reduced, whereas lipid oxidation was increased (all P < 0.05). Insulin down-regulated PP2A-C alpha expression in skeletal muscle of the control subjects (P < 0.05) but not in the type 2 diabetic subjects. In the control subjects, the insulin-mediated decrease in PP2A-C alpha correlated with the insulin-mediated increase in glucose disposal, glucose oxidation, nonoxidative glucose metabolism (all P < 0.05) and decrease in lipid oxidation (P < 0.01). In the type 2 diabetic subjects these relationships were absent.
CONCLUSIONS: Down-regulation of PP2A-C alpha expression by insulin in skeletal muscle seems to be associated with a normal insulin action on glucose storage, glucose and lipid oxidation. Impaired down-regulation of PP2A-C alpha expression by insulin may be a marker for insulin resistance and contribute to the pathogenesis of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12534451     DOI: 10.1046/j.1365-2362.2002.01098.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

1.  Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d.

Authors:  Biny K Joseph; Hsing-Yin Liu; Jamie Francisco; Devanshi Pandya; Melissa Donigan; Christina Gallo-Ebert; Caroline Giordano; Adam Bata; Joseph T Nickels
Journal:  J Biol Chem       Date:  2015-02-18       Impact factor: 5.157

Review 2.  Ser/Thr phosphatases: One of the key regulators of insulin signaling.

Authors:  Yamini Yadav; Chinmoy Sankar Dey
Journal:  Rev Endocr Metab Disord       Date:  2022-06-13       Impact factor: 9.306

3.  Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Khortnal Delvecchio; Han-Zhong Feng; Gregory D Cartee; Jian-Ping Jin; Assia Shisheva
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

4.  Increased ceramide content and NFκB signaling may contribute to the attenuation of anabolic signaling after resistance exercise in aged males.

Authors:  Donato A Rivas; Evan P Morris; Prashanth H Haran; Evan P Pasha; Mauricio da Silva Morais; Gregory G Dolnikowski; Edward M Phillips; Roger A Fielding
Journal:  J Appl Physiol (1985)       Date:  2012-10-04

5.  High glucose exposure promotes activation of protein phosphatase 2A in rodent islets and INS-1 832/13 β-cells by increasing the posttranslational carboxylmethylation of its catalytic subunit.

Authors:  Daleep K Arora; Baker Machhadieh; Andrea Matti; Brian E Wadzinski; Sasanka Ramanadham; Anjaneyulu Kowluru
Journal:  Endocrinology       Date:  2013-11-21       Impact factor: 4.736

6.  Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice.

Authors:  Huijuan Jia; Wanping Aw; Kenji Egashira; Shoko Takahashi; Shinya Aoyama; Kenji Saito; Yoshimi Kishimoto; Hisanori Kato
Journal:  Genes Nutr       Date:  2014-03-06       Impact factor: 5.523

7.  Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.

Authors:  C M Frederiksen; K Højlund; L Hansen; E J Oakeley; B Hemmings; B M Abdallah; K Brusgaard; H Beck-Nielsen; M Gaster
Journal:  Diabetologia       Date:  2008-08-22       Impact factor: 10.122

8.  A PP2A regulatory subunit regulates C. elegans insulin/IGF-1 signaling by modulating AKT-1 phosphorylation.

Authors:  Srivatsan Padmanabhan; Arnab Mukhopadhyay; Sri Devi Narasimhan; Gregory Tesz; Michael P Czech; Heidi A Tissenbaum
Journal:  Cell       Date:  2009-02-26       Impact factor: 41.582

Review 9.  All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.

Authors:  Jaya Sangodkar; Caroline C Farrington; Kimberly McClinch; Matthew D Galsky; David B Kastrinsky; Goutham Narla
Journal:  FEBS J       Date:  2015-11-14       Impact factor: 5.542

10.  Palmitate action to inhibit glycogen synthase and stimulate protein phosphatase 2A increases with risk factors for type 2 diabetes.

Authors:  David M Mott; Karen Stone; Mary C Gessel; Joy C Bunt; Clifton Bogardus
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-12-04       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.